NASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis $20.09 -0.71 (-3.41%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$19.97▼$21.3350-Day Range$20.04▼$27.9252-Week Range$18.07▼$41.02Volume1.03 million shsAverage Volume1.20 million shsMarket Capitalization$1.80 billionP/E RatioN/ADividend YieldN/APrice Target$27.20 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Fortrea alerts: Email Address Fortrea MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside35.4% Upside$27.20 Price TargetShort InterestHealthy7.47% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.60Based on 3 Articles This WeekInsider TradingAcquiring Shares$50,600 Bought Last QuarterProj. Earnings Growth156.67%From $0.60 to $1.54 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.49 out of 5 starsMedical Sector252nd out of 910 stocksMedical Laboratories Industry9th out of 18 stocks 4.2 Analyst's Opinion Consensus RatingFortrea has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 7 hold ratings, and 1 sell rating.Amount of Analyst CoverageFortrea has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fortrea's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted7.47% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in Fortrea has recently decreased by 18.16%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FTRE. Previous Next 2.0 News and Social Media Coverage News SentimentFortrea has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Fortrea this week, compared to 4 articles on an average week.Search Interest5 people have searched for FTRE on MarketBeat in the last 30 days. MarketBeat FollowsOnly 2 people have added Fortrea to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have bought more of their company's stock than they have sold. Specifically, they have bought $50,600.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 0.12% of the stock of Fortrea is held by insiders.Read more about Fortrea's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Fortrea are expected to grow by 156.67% in the coming year, from $0.60 to $1.54 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fortrea is -14.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fortrea is -14.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioFortrea has a PEG Ratio of 2.27. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 1.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Fortrea's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsNASDAQ to crash 50%?During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out... Now, he's saying there are four major cracks forming in the US economy...Click here to learn more >>> About Fortrea Stock (NASDAQ:FTRE)Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Read More FTRE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FTRE Stock News HeadlinesSeptember 3, 2024 | americanbankingnews.comCareDx (NASDAQ:CDNA) versus Fortrea (NASDAQ:FTRE) Financial AnalysisSeptember 2, 2024 | americanbankingnews.comFortrea (NASDAQ:FTRE) & Burning Rock Biotech (NASDAQ:BNR) Head-To-Head SurveySeptember 7, 2024 | Behind the Markets (Ad)Is Warren Buffett preparing for a 50% market crash?Billionaire investor Warren Buffet just dumped 60% of his Apple shares! Other billionaires like Mark Zuckerberg, Jeff Bezos, and the Walton family have sold billions of dollars worth of shares in their own companies as well. Are these billionaires quietly preparing for a historic market crash?August 18, 2024 | finance.yahoo.comFortrea Holdings Second Quarter 2024 Earnings: Misses ExpectationsAugust 17, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$1.08m On Fortrea HoldingsAugust 14, 2024 | markets.businessinsider.comFortrea Holdings Inc.: Hold Rating Affirmed Amidst Reduced Earnings Projections and Cautious OutlookAugust 14, 2024 | msn.comFortrea Holdings Inc. (NASDAQ:FTRE) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comFortrea Holdings: Continued TroublesSeptember 7, 2024 | Behind the Markets (Ad)Is Warren Buffett preparing for a 50% market crash?Billionaire investor Warren Buffet just dumped 60% of his Apple shares! Other billionaires like Mark Zuckerberg, Jeff Bezos, and the Walton family have sold billions of dollars worth of shares in their own companies as well. Are these billionaires quietly preparing for a historic market crash?August 12, 2024 | bizjournals.comBillion-dollar Durham firm slashes revenue goals as stock cratersAugust 12, 2024 | seekingalpha.comFortrea Holdings Inc. (FTRE) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | markets.businessinsider.comFortrea Holdings Inc. Q2 Earnings SummaryAugust 12, 2024 | investorplace.comFTRE Stock Earnings: Fortrea Holdings Misses EPS, Misses Revenue for Q2 2024August 12, 2024 | globenewswire.comFortrea Reports Second Quarter 2024 ResultsAugust 8, 2024 | msn.comEvercore ISI Group Downgrades Fortrea Holdings (FTRE)July 24, 2024 | finance.yahoo.comFTRE Nov 2024 37.500 call (FTRE241115C00037500)July 19, 2024 | markets.businessinsider.comDemystifying Fortrea Holdings: Insights From 8 Analyst ReviewsJuly 17, 2024 | globenewswire.comFortrea Announces Date for Second Quarter 2024 Financial Results and Conference CallSee More Headlines Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/12/2024Today9/07/2024Next Earnings (Estimated)11/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryHealthcare Current SymbolNASDAQ:FTRE CUSIPN/A CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees18,000Year FoundedN/APrice Target and Rating Average Stock Price Target$27.20 High Stock Price Target$44.00 Low Stock Price Target$21.00 Potential Upside/Downside+35.4%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($1.39) Trailing P/E RatioN/A Forward P/E Ratio33.48 P/E Growth2.27Net Income$-3,400,000.00 Net Margins-10.09% Pretax Margin-7.28% Return on Equity1.98% Return on Assets0.78% Debt Debt-to-Equity Ratio0.77 Current Ratio1.19 Quick Ratio1.19 Sales & Book Value Annual Sales$3.01 billion Price / Sales0.60 Cash Flow$2.17 per share Price / Cash Flow9.27 Book Value$16.31 per share Price / Book1.23Miscellaneous Outstanding Shares89,400,000Free Float89,293,000Market Cap$1.80 billion OptionableOptionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Thomas H. Pike (Age 65)CEO, President & Chairman Comp: $2.19MMs. Jill McConnell (Age 49)Chief Financial Officer Comp: $735.39kMr. Mark A. Morais (Age 47)COO & President of Clinical Services Comp: $732.47kAmanda M. WarrenChief Accounting OfficerMs. Hima B. InguvaHead of Investor Relations & Corporate DevelopmentStillman HansonGeneral Counsel & Corporate SecretaryDr. John J. DoylePresident of ConsultingMore ExecutivesKey CompetitorsPACS GroupNYSE:PACSOption Care HealthNASDAQ:OPCHSotera HealthNASDAQ:SHCSurgery PartnersNASDAQ:SGRYConcentra Group Holdings ParentNYSE:CONView All CompetitorsInsiders & InstitutionsSanctuary Advisors LLCBought 14,164 shares on 9/5/2024Ownership: 0.016%Truist Financial CorpSold 74,014 shares on 8/21/2024Ownership: 0.264%Brandes Investment Partners LPBought 519,344 shares on 8/19/2024Ownership: 2.727%William B. Walkup & Associates Inc.Bought 9,386 shares on 8/16/2024Ownership: 0.010%Algert Global LLCBought 8,552 shares on 8/16/2024Ownership: 0.010%View All Insider TransactionsView All Institutional Transactions FTRE Stock Analysis - Frequently Asked Questions How have FTRE shares performed this year? Fortrea's stock was trading at $34.90 at the start of the year. Since then, FTRE shares have decreased by 42.4% and is now trading at $20.09. View the best growth stocks for 2024 here. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) released its quarterly earnings results on Monday, August, 12th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by $0.10. The company's revenue for the quarter was down 8.6% on a year-over-year basis. Who are Fortrea's major shareholders? Top institutional shareholders of Fortrea include Sessa Capital IM L.P. (7.55%), Baupost Group LLC MA (3.51%), Victory Capital Management Inc. (2.76%) and Brandes Investment Partners LP (2.73%). Insiders that own company stock include Thomas Pike and Peter M Neupert. View institutional ownership trends. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FTRE) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredThese 2 simple sentences turn every Friday into payday?Most people have never heard of Jim Fink. Behind his humble demeanor and insistence on personal privacy... ...Investing Daily | SponsoredHere’s A Painful Truth and 100% Fact About The Stocks You’re HoldingCharles Payne here, and I want to let you in on an uncomfortable truth that long term investors and retirees n...Unstoppable Prosperity | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredLast Call for Crypto Summit (RSVP FREE)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortrea With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FTRE Stock Alerts